Happy to report that our Young Investigator Award, "Metabolic reprogramming of tumor-specific T cells for immunotherapy," was funded through the Alliance for Cancer Gene Therapy! This award supports research using genetic engineering to create superior, long-lived T cell for the treatment of murine cancer, and using that model to generate superior human T cells!